Rik Somford

Confocal laser microscopy may provide a quick method for intraoperative margin assessment during #prostatectomy. Read more 👇 prostate.uroonco.uroweb.org/publication/co… @dmsomford @saskiazomer @roodvdb

Risk-calculator and MRI guidance dramatically improve the diagnostic pathway for PCa, with comparable rates of significant disease and more biopsies avoided with MRI. 👇 prostate.uroonco.uroweb.org/publication/a-… #prostatecancer @IvoSchootsNL @JelleBarentsz @dmsomford @roodvdb @SjoerdKlaver

@roodvdb @MRvanBalken @UrologieTwente @TweetUroloog Sportief vak, we hebben een hele kledinglijn:

De polo is het nieuwe normaal binnen de urologie! 👕 @MRvanBalken @UrologieTwente @TweetUroloog @dmsomford

Mocht je de collectant van @kwf_nl aan de deur gemist hebben, dan kun je nog via ons team steunen op: acties.kwf.nl/fundraisers/di… #KWF #collecteweek

Piquing clinician's curiosity in Prostate Cancer. Back in Dec 2020 with Dr. Rochat, who would have guessed that it would be the trigger to another great collaboration with Prosper Prostate Cancer Clinics in the Netherlands. #prostate#prostatectomy#prostatecancer#cliniquebeaulieu

@roodvdb @EAU_Uroonco @luca_sarchi @SimoneAssumma @bernardorocco73 @MariaChiaraMCS @AlessiaCim @PuliattiStefano @EUplatinum Comparative study with ‘gold standard’ #NeuroSafe for intra-operative surgical margin assessment in radical prostatectomy is underway! Please feel invited to come over and have a look.

@EAU_Uroonco @luca_sarchi @SimoneAssumma @bernardorocco73 @MariaChiaraMCS @AlessiaCim @PuliattiStefano @EUplatinum @dmsomford

Digital frozen section technique during robot #prostatectomy using fluorescence confocal microscopy. Read more 👇 prostate.uroonco.uroweb.org/publication/di… #prostatecancer @luca_sarchi @SimoneAssumma @bernardorocco73 @MariaChiaraMCS @AlessiaCim @PuliattiStefano @roodvdb @EUplatinum

@EAU_Uroonco @luca_sarchi @SimoneAssumma @bernardorocco73 @MariaChiaraMCS @AlessiaCim @PuliattiStefano @roodvdb @EUplatinum Most likely a cost-effective and user-friendly alternative to the elaborate #NeuroSafe procedure. Our first experience with confocal laser microscopy is very exciting, but we need to learn how to interpret whole surface imaging as compared with segmental techniques such as NS.

Mooie innovatie van Samantree die we met veel enthousiasme gaan valideren voor gebruik bij intra-operatieve beoordeling van snijvlakken bij radicale prostatectomie binnen prosperklinieken.nl @diedbaas @CWZNijmegen #pcsm ⁦@SiouxSource⁩ linkedin.com/posts/samantre…

External Validation and Addition of Prostate-specific Membrane Antigen... sciencedirect.com/science/articl…

#ProstateCancer is the 2nd most frequent cancer in men. In 2020, there were around 1.4 million new cases and the disease is set to become a much bigger burden globally. Read about the aims of new @TheLancet Commission on Prostate Cancer: hubs.li/H0Nf7vY0

Bounce is better; review on PSA bounce after radiation for #prostatecancer. Read more 👇 prostate.uroonco.uroweb.org/publication/pr… #GUcancer @roodvdb @pcan_journal

177Lu-PSMA-617 radioligand-therapy appears to be a feasible and safe treatment modality in patients with low volume metastatic hormone-sensitive #ProstateCancer. @BP @onco_uroloog niven.mehra @dmsomford @JelleBarentsz bit.ly/3nCuybm

Trots en vereerd dat ons onderzoek geïnitieerd vanuit prosperklinieken.nl door KWF wordt ondersteund! Dank aan alle donateurs die dit mogelijk maken!

The impact of MRI on #activesurveillance discontinuation and the need to adapt AS criteria. Read more 👇 prostate.uroonco.uroweb.org/publication/wh… #prostatecancer @DrJessRueb @dmsomford @roodvdb

Tijd voor een experimentje! npo3.nl/de-kalvijn-sho…

nature.com/articles/s4139… The effects of new life-prolonging drugs (LPD) for #mCRPC patients in a real-world population shows that since 2010, a larger proportion of mCRPC patients was treated with LPDs, which was related to an increased median OS.#prostatecancer

🆕The POP-RT study showed more favourable biochemical & disease-free survival rates for patients with a whole pelvic radiation vs. prostate only. Learn more about the outcomes with this UROONCO PCa Article of the Month & commentary. prostate.uroonco.uroweb.org/publication/pr… @roodvdb

@robo_vis @piet_ost @roodvdb @Issarami @PCaParker @GeorgesUrology @HARQazi @roboturologist @alison_tree @Prof_Nick_James Agree that focus should be on the PSMA positive population. PSMA negative patients with pN1 at PLND do better than PSMA-positive patients and therefor we should not omit PLND in the PSMA-negative high-risk population. Right strategy for intermediate-risk also remains unclear.

@piet_ost @roodvdb @Issarami @PCaParker @GeorgesUrology @HARQazi @roboturologist @alison_tree @Prof_Nick_James Interesting question. Do we not treat PSMA positive disease (miN1) by local therapy because of high recurrence rates? The treatment of lymph node positive disease is one of the most unexplored domains in urology. We need to establish well performed clinical trials...

That's why we often avoid surgery in patients with positive nodes on PSMA @GeorgesUrology. Remember that PSMA shows only the tip of the iceberg. @HARQazi @roboturologist @alison_tree @PCaParker

Essentieel personeel in de ziekenhuizen moet snel gevaccineerd worden, vinden Ernst Kuipers en Diederik Gommers. Gommers roept op om aanstaande maandag in ziekenhuizen te beginnen met vaccineren #Nieuwsuur